Justin Trojanowski insider trades
Open-market stock purchases and sales by Justin Trojanowski, Corporate Controller at Tempest Therapeutics, Inc, from SEC Form 4 filings since Oct 3, 2022.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -76%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 31, 2026 | TPST Tempest Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- TPST Tempest Therapeutics, Inc: 1 buy, last Mar 31, 2026